11,633.30-45.2
Stock Analysis, IPO, Mutual Funds, Bonds & More

The aim is to push HUL to No 2 in five years: Ramdev

Patanjali will touch Rs 25,000 crore in revenue by the end of the current fiscal year.

ET Bureau|
Last Updated: Jan 25, 2020, 04.24 PM IST
0Comments
Thumb (56)
Baba Ramdev-led Patanjali Ayurved will touch Rs 25,000 crore in revenue by the end of the current fiscal year, the yoga guru said on Friday.

Ramdev said consumption is expected to start showing signs of recovery in the coming financial year and that Patanjali was not actively pursuing international joint ventures for now.

“We have multiple offers from MNCs on the same; at this point, we are looking to consolidate domestic operations,” he said. Of the Rs 25,000-crore target, Ramdev said Rs 12,000 crore will come from its core Patanjali business, while the rest will be from Ruchi Soya, the debt-ridden edible oils maker that it had acquired in a corporate insolvency resolution for about Rs 4,500 crore.

Patanjali, which has positioned itself as a ‘swadeshi’ alternative to multinational daily use products, said it was moving towards becoming the country’s largest FMCG company in the coming years.

“Over the next five years or so, we will have a turnover of around Rs 50,000 crore to Rs 1 lakh crore and will become the largest FMCG company ahead of Hindustan Unilever (HUL),” Ramdev said.

HUL, India’s biggest packaged consumer goods company, reported revenue of more than Rs 38,000 crore in the previous fiscal year, and this is expected to increase significantly once its merger with health foods maker GSK Consumer Healthcare is completed.

The Ayurveda products maker, which had forced global and local players including HUL, L’Oréal, Colgate Palmolive and Dabur to step up their Ayurveda portfolios, is now facing tough competition from both global and local players.

Also Read

HUL reshuffles top management team

HUL to set up subsidiary to save on tax

HUL grows slowest in Q3 since demonetisation

HUL to increase soap prices by 5-6 pc

Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service